cdri 85-287 has been researched along with ly 117018 in 3 studies
Studies (cdri 85-287) | Trials (cdri 85-287) | Recent Studies (post-2010) (cdri 85-287) | Studies (ly 117018) | Trials (ly 117018) | Recent Studies (post-2010) (ly 117018) |
---|---|---|---|---|---|
22 | 0 | 3 | 105 | 0 | 0 |
Protein | Taxonomy | cdri 85-287 (IC50) | ly 117018 (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.12 | |
Estrogen receptor beta | Homo sapiens (human) | 0.12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kon, OL; Ng, SC; Sim, KY; Teo, CC | 1 |
Durani, S; Kapil, RS; Saeed, A; Sharma, AP | 2 |
3 other study(ies) available for cdri 85-287 and ly 117018
Article | Year |
---|---|
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
Topics: Benzofurans; Binding Sites; Binding, Competitive; Cell Division; Cell Line; Cholesterol; Estrogen Antagonists; Humans; Ligands; Receptors, Estrogen; Thymidine | 1992 |
Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
Topics: Animals; Benzopyrans; Binding, Competitive; Chemical Phenomena; Chemistry; Cytosol; Estrogen Antagonists; Female; Mice; Molecular Structure; Organ Size; Phenols; Piperidines; Rats; Receptors, Estrogen; Structure-Activity Relationship; Uterus | 1990 |
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
Topics: Animals; Benzopyrans; Binding, Competitive; Chemical Phenomena; Chemistry; Cytosol; Estrogen Antagonists; Female; Mice; Microsomes, Liver; Molecular Structure; Organ Size; Piperidines; Pyrrolidines; Rats; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus | 1990 |